In conclusion, CIRBP is downregulated in pancreatic cancer and can induce ferroptosis by regulating the p53/GPX4 pathway, thereby inhibiting cell growth and playing the role of tumor suppressor gene, indicating that it may be an important target for the diagnosis and treatment of pancreatic cancer. This evidence concerns the gene TP53 and familial pancreatic carcinoma.